Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07319442

CEDUR - German IBD Registry

Long-term Observation of IBD Patients, a Nationwide German IBD Registry "CEDUR"

Status
Recruiting
Phase
Study type
Observational
Enrollment
10,000 (estimated)
Sponsor
ImmunoRegister gUG · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The CEDUR registry systematically collects real-world data on inflammatory bowel disease (IBD) patients in Germany. The registry aims to assess quality of care, disease activity, treatment effectiveness, safety, and pharmacoeconomic aspects under routine clinical conditions.

Detailed description

CEDUR is a multicenter, web-based, observational registry for adult IBD patients in Germany. The registry includes Crohn's disease, ulcerative colitis, and indeterminate colitis. Data are collected prospectively from physicians and patients, covering clinical parameters, quality of life, treatment patterns, and safety outcomes. The registry supports the evaluation of care quality, cost-effectiveness, and long-term therapy outcomes under real-life conditions.

Conditions

Timeline

Start date
2018-05-03
Primary completion
2036-05-01
Completion
2036-05-01
First posted
2026-01-06
Last updated
2026-01-06

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT07319442. Inclusion in this directory is not an endorsement.

CEDUR - German IBD Registry (NCT07319442) · Clinical Trials Directory